We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Mortality Higher in Women Following AAA Endovascular Repair

By HospiMedica International staff writers
Posted on 11 Mar 2020
Women with abdominal aortic aneurysm (AAA) are more likely to undergo open repair than men, and are also more likely to die after endovascular repair, according to a new study.

Researchers at the Dartmouth Institute for Health Policy and Clinical Practice (DTI; Lebanon, NH, USA), the Geisel School of Medicine (Hanover, NH, USA), and other institutions conducted a cohort study involving 16,386 patients (65 years or older) – of which 77.9% were men and 22.1% were women--to determine if a sex-related difference exists in mortality risk after AAA repair. More...
The influence of differences in repair type (endovascular or open surgical repair) were also reviewed. The data was extracted from the U.S. Vascular Quality Initiative clinical registry and Medicare claims.

In all, 27% of the women underwent surgical AAA repair, compared to 18% of men. The results revealed that 10-year unadjusted survival with endovascular repair was 23% for women and 37% for men, which remained significant after adjustment; 10-year mortality after open surgery was 36% for men and 32% for women. Overall, women were 65% more likely to undergo open surgery, and had 13% greater risk-adjusted 10-year mortality after endovascular repair. Mortality after open surgical repair was similar for men and women. The study was published on February 5, 2020, in JAMA Open Network.

“Physicians should recognize that the optimal, evidence-based strategy for AAA treatment to maximize postoperative survival may be sex specific, and explore new techniques and devices to extend the benefits of endovascular repair treatment to women,” concluded lead author Niveditta Ramkumar, MPH, and colleagues. “Women appear to have more complex aortic anatomy, and developing grafts specifically for female patients could help improve outcomes.”

AAA is the localized dilatation of the abdominal aorta exceeding the normal diameter by more than 50%, and is the most common form of aortic aneurysm; approximately 90% occur below the kidneys. The aneurysms can extend to include one or both of the pelvic iliac arteries. The major complication of AAA is rupture, which is life-threatening, as large amounts of blood spill into the abdominal cavity, and can lead to death within minutes. Mortality of rupture repair in the hospital is 60-90%.

Related Links:
Dartmouth Institute for Health Policy and Clinical Practice
Geisel School of Medicine



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.